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http://dx.doi.org/10.1016/j.hkjn.201Summary Peritoneal dialysis as a modality can offer its patients several advantages including
increased independence, no need for regular hospital or center visits, and fewer lost work hours.
However some, disadvantages such as leaving the complete onus on the patient to do his own
therapy and being far away from the nephrologist can lead to unwillingness or a fear of choosing
PD.Over the last few years, our PDunit has developed aPD remotemonitoring protocol using sim-
ple and easily available, technology like digital cameras, and mobile telecommunication along
with a regular home visit, schedule. The aim of this protocol is to reduce the mental burden of
PD, to reduce the complexity of the, procedure, to keep the nephrologist well informed about
the patient status, and to ensure adherence to, the proper technique. In this article we explain
our process and corroborate its usefulness with the, help of two studies conducted in our center.
對於病人而言，腹膜透析 (PD)的優點包括較佳的獨立性、定期院所回訪的豁免、及較少工作時間
的喪失；缺點則是病人必須完全承擔自身治療的責任、及較少接受腎科醫生診察的機會，可能降
低病人選擇接受PD的意願。在過去數年間，我們的PD中心發展出一套PD遠距監測辦法，透過採
用簡單且平常的途徑，如數位攝影機與流動通訊系統，並合併定期的家訪實施，其目的包括：減
少病人對PD的心理負擔、降低整個PD實施過程的複雜程度、確保腎科醫生對病人狀況的掌握、
及確保病人對正確技巧的遵循。本文對此辦法的實施作出介紹，並透過本中心的2項相關研究，
對其潛在用途作出探討。Introduction
Peritoneal dialysis (PD) as a modality has always been
underutilized in most parts of the world. A long list ofail.com (A. Nayak Karopadi).
g Kong Society of Nephrology Ltd
3.03.002reasons including economic burden, lack of sufficient dial-
ysis education, inordinately high peritonitis rates in new
users of PD, technique failure, long waiting period for
catheter implantation surgery, and lack of financial. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1 Characteristics of the patients in this study.
Characteristic Group pa
Rural Urban
Patients (n) 115 131 NS
Mean age (y) 51.49  12.8 52.32  12.59 NS
Sex, men/women 69.6/30.4 68.7/31.3 NS
Cumulative follow-up (pt-mos) 2008 2288 NS
Cause of ESRD
Diabetic nephropathy (35.7%) 39.3 36.4 NS
Chronic TIN 34.3
Modes of communication (n)
Mobile phone 115 131 NS
Land line 115 131 NS
Internet at home 48 55 NS
Technique failure 25.30 20.6 NS
Technique survival 79.20 74.60 NS
Patient survival 42.60 29.80 <0.05
Peritonitis rate (ep/pt-mos) 1/40.3 1/34.8 NS
ESIs (ep/pt-mos) 1/56.6 1/51.2 NS
Data are presented as % unless otherwise stated.
ep Z episodes; ESIs Z exit-site infections; ESRD Z end-stage renal disease; NS Z nonsignificant; pt-mos Z patient-months;
TIN Z tubulointerstitial nephritis.
a By Fisher’s exact test.
Figure 1 Details for the patient on peritoneal dialysis, sent
through the Short Messaging Service to the Mother Unit for
response and follow-up.
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sons why the world average PD utilization rate is only 11%.1
PD is only popular in a few countries such as Hong Kong,
Mexico, and New Zealand, and this is because their gov-
ernments have instituted PD first policies.
In our experience with PD patients, we have realized that
a successful PD program is heavily dependent on a well-
structured and flexible follow-up system.9,10,20,21,26 Our PD
program places the patient’s interests at the highest priority
level and strives to preserve quality of life, to maintain close
contact with clinical coordinators (CCs) and nephrologists,
and to reduce the patient’s mental stress due to performing
PD on his own. Our PD program focuses on early detection of
evolving comorbidities, proper technique adherence,
monitoring of nutritional status, and an orderly follow-up
system to ensure patient compliance and rehabilitation.13
These provisions are implemented in order to minimize the
possibility of any further complication or episode that would
require special intervention or hospitalization. The system
can not only reduce the financial stress on patients and their
families but can also reduce intangible “costs”, such as
suffering and loss of productivity of the patient and family
members due to extra hospitalizations. Another added
advantage of such a system is the fact that the patient’s
geographical location is immaterial. The patient can be
assured of a safe and regularly monitored PD therapy even if
he lives in a very remote location.12
The need for remote monitoring
It is true that PD gives the patient the possibility of carrying
out dialysis at home and without having to travel to a
hospital or a center frequently.15e17 On the downside, the
patient is more cut off from the doctor or any medical
attention, the patient or his family needs to bear theburden of conducting exchanges, there is a higher chance
that a complication will be undetected, and there are much
higher chances of wrong techniques being used as well.2e5
These are the demerits of PD that lead to “Fear of PD” or
“Unwillingness to do PD.” An article by Kawaguchi in
2007,30 which discussed the various “obstacles to PD growth
in Japan,” noted that unwillingness on the part of the pa-
tient and his family is one of the reasons why PD utilization
is so low in Japan. This is also reflected in the fact that the
Figure 2 Process overview of the peritoneal dialysis remote monitoring system. SMSZ Short Messaging Service; USBZ universal
serial bus connection technology; PD Z peritoneal dialysis.
8 A. Nayak Karopadi et al.current PD utilization rate in Japan is only 3.4%1 and the
growth rate is almost zero.
Remote monitoring can be described as an intimate
contact (in spite of inaccessibility) between the patient and
the nephrologist through digital means, that is, Internet,
mobile telephone, video, and image transfers. The purpose
of remote monitoring is to make sure that the nephrologist
is well informed about the status of all his patients through
regularly updated information.22e25
Remote monitoring can help simplify the therapy pro-
cedure for the patient or his family through a user-friendly
walkthrough (supplemented with interactive audiovisual
cues), help enforce the correct technique, and help keep
track of exchange details and patient status (using elec-
tronic medical records). We feel that remote monitoring of
PD can have a direct impact on technique survival, days of
hospitalization, and patient dropout rates. In our opinion, it
is absolutely necessary for remote monitoring of patients
who live in inaccessible or rural areas. Overall, remote
monitoring is not only a potential solution for acceptance of
PD, but is also a good method for reducing the mental stress
experienced by the patient and his family due to the
burden of end-stage renal disease (ESRD).
Use of technology
According to a study by Rosner and Ronco in 2012,14 the
requirements for a remote monitoring system are as fol-
lows: (1) the ability to allow user flexibility in movement
and activities; (2) two-way communications including high-
definition video; (3) a simple and intuitive alarm system
with a high degree of specialty and sensitivity for clinically
appropriate alarms; (4) modifiable and customizable (e.g.,
monitoring capability at the beginning of training and first
months of therapy may be more intensive and then scaled
back as appropriate); (5) it should generate useful reports
that can be used to monitor quality; and (6) it should not be
intrusive and should maintain portability.Considering the preceding requirements, several basic
technologies can be used especially in countries such as
India including mobile phone communication, e-mail and
chat services, and inexpensive digital cameras.
In our center, we have made extensive use of the Internet
for record maintenance, mobile phone technology for data
collection including general status [short message service
(SMS) feature] and image transfer (mobile phonecamera), and
a digital camera for video transfer and high-definition images.
We have a dedicated PD team consisting of trained medical
and paramedical staff who have been trained to be proficient
in using all the mentioned technologies and also train the pa-
tient to performexchangeswith the compliance required for a
safe and easy PD therapy.18 We are currently developing an
application for the iPad that will be used for capturing videos
and images and sending all the exchange data directly to an
online database. It is our opinion that this application can be a
one-stop solution toall therequirementsof remotemonitoring
and can help simplify the entire process even further.
Following is a diagram that explains our current process.
Home visit protocol
Our system relies heavily on regular patient home visits. The
home visit schedules are prepared by the clinical head and
conducted by the CCs. The CCs are required to follow a step-
by-step assessment of patient well-being every time they
visit. The CC visits are generally scheduled such that the CCs
can monitor an exchange being performed by the patient or
by the patient’s primary caregiver. This is to ensure that the
proper technique is being followed. The CC is also required
to do a thorough check of the PD logbook and to identify any
condition(s) that might require the attention of the
nephrologist. In addition to the most current laboratory re-
sults, the CC is also required to check for exit-site infections
and signs of pedal edema, and must also examine the
effluent bag for signs of peritonitis. The CC also advises the
patient about nutrition status, psychological well-being,
Figure 3 The interface shows patient details and peritoneal dialysis images in horizontal and vertical orientation, with zoom
available for closer inspection and a print background for effluent clarity determination.
Remote monitoring of peritoneal dialysis 9physical fitness, and rehabilitation levels after they finish
their complete assessment. After a successful completion of
the home visit, the CC enters all the above-mentioned de-
tails into the referral PD unit records.12
The theme of our home visit protocol is to nip incorrect
practices in the bud before they become a serious problem.
This can also be thought of as post-training follow-up to
ensure the highest form of compliance.Remote monitoring system
We have created a web-based remote monitoring system
that keeps track of each and every patient. Thenephrologist has access to all patient records through an
online database that contains information about every
single exchange performed by every single patient. The
web-based system also allows real-time interaction be-
tween patients and primary healthcare providers through
online chats.
Patients can also use their online accounts to register
complaints on the online system, which is visible to the
nephrologist and the CCs. They are directed to a page
where they are required to give a brief account of their
current concerns, and they can also use it to pose pertinent
questions. The remote monitoring system keeps the doctors
aware of the status of every patient, and it can also be used
to schedule an emergency home visit.12
Figure 4 Bi-directional real-time exchange and communication between patient and medical caregivers.
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Study examining clinical aspects
In May 2003, 246 patientswho had started on PD at our center
and who had used this accessibility technology in their day-
to-day care were retrospectively analyzed. They were
divided into two clinically equivalent groups: the rural group
(115 patients) and the urban group (131 patients). An urban
area is defined as a place with a municipal corporation,
municipal board, or cantonment board, or as a region in a
notified town area.6 All other areas that satisfy the criteria
of having at least 75% of the male working population
engaged in nonagricultural or allied activity, and a popula-
tion density of at least 400/km2, are also considered urban.
Areas that do not fall under these criteria are considered
rural.12
Every patient’s primary “caregiver” or additional skilled
family member, or both, are compulsorily trained to use a
digital camera, mobile phone camera, and the Internet to
send images of PD solution bags, exit sites, and other as-
pects of interest. Their demographic data; ESRD diagnosis
and cumulative follow up; mode of communication; PD
technique survival and failure and patient survival rates (all
at 5 years); and peritonitis and exit-site infection rates
were analyzed (Table 1) using SPSS software application
(version 16: SPSS, Chicago, IL, USA).Table 2 Summary of data for all patient groups.
Group Mean  SD
age (y)
Diabetic
nephropathy
incidence
Hypertension
incidence
I (n Z 22) 47.84 (12.90) 42 (51) 74 (45)
II (n Z 18) 53.05 (16.30) 63 (50) 79 (42)
III (n Z 40) 50.45 (14.74) 53 (51) 76 (43)
IV (n Z 20) 51.21 (15.57) 37 (50) 79 (42)
Data are presented as % or (SD).A summary of our results is shown in Table 1. The patient
cohort that used the remote monitoring system on a day-to-
day basis included 115 rural and 131 urban patients. The
mean follow-up period was 4296 patient-months (2008 in the
rural group, 2288 in the urban group). The mean age was
51.49 12.8 years in the rural group and 52.32 12.59 years
in the urban group. The most common cause of ESRD was
diabetic nephropathy in both groups (39.3% in the rural
group, 36.4% in the urban group). Chronic tubulointerstitial
nephritis was the second most common diagnosis in both
groups (35.7% in the rural group, 34.3% in the urban group).
Technique failure rateswere 25.3% and 20.6% in the rural and
urban groups, respectively (p > 0.05), and peritonitis rates
were 1 episode in 40.3 patient-months (rural) and 1 episode
in 34.8 patient-months (urban, p> 0.05). Exit-site infections
occurred at a rate of 1 episode in 56.6 patient-months (rural)
and 1 episode in 51.2 patient-months (urban, p > 0.05).
Patient survival at 5 years was significantly better in rural
patients (42.6% vs. 29.8% in the urban group, p< 0.05; Table
1). Overall, rural patients performed well on PD and had
significantly better survival rates compared with their urban
counterparts, contrary to what might have been expected.
Our monitoring strategies allow for earlier diagnosis of in-
fectious PD complications, thus promoting promptTable 3 Quality of life (SF-36) results of the study.a
Group PCS score p MCS score p
I 34.3 48.4
II 33.7 48.2
Difference 0.6 >0.05 0.2 >0.05
III 34.0 48.3
IV 29.7 43.3
Difference 4.3 0.012 5.0 0.012
a SF-36 scores are divided into mean physical component
summary (PCS) scores and mean mental component summary
(MCS) scores.
Table 4 Results of the economic survey.
Group I II Difference p III IV Difference p
Basic treatment cost 6588 6188 470 >0.05 6353 7176 823 >0.05
Laboratory testing cost 376 459 83 >0.05 418 471 53 >0.05
Erythropoietin cost 753 1271 518 0.0063a 1012 1976 964 <0.001a
Hidden costs 915 2286 1371 0.0056a 1600 5264 3664 <0.001a
Complication costs 1363 2005 642 >0.05 1684 1598 86 >0.05
a All costs are calculated on a yearly basis and in US$ ($1.00 Z INR 54).
Remote monitoring of peritoneal dialysis 11treatment initiation and response. Most of our rural patients
visit the unit once in 3e6 months on a “as needed” basis.
Study examining cost, quality of life, and depression
scores
Based on the inclusion criteria, patients with ESRD initiated
on PD between August 2008 and October 2008 and hemodi-
alysis (HD) between July 2008 and October 2008 were
included in the study. The PD patients were subdivided into
Group I if they were from rural areas and Group II if they
were from an urban setting. Group III is a consolidated group
consisting of all patients on PD, which include patients from
Group I and Group II. Group IV consisted of patients initiated
on HD with ESRD. Patients who were diagnosed with clinical
depression were dropped from the study.31
A total of 60 patients were eligible for the study. Group I
had 22 patients, Group II had 18, Group III had 40, and Group
IV had 20 patients. All patients were asked to respond to a
set of three questionnairesdthe Short Form-36 (SF-36)
Health Survey, Beck Depression Inventory-II (BDI-II), and a
specially prepared financial analysis questionnaire. The use
of the SF-36 form to analyze patient quality of life as well as
the use of the BDI-II form for depression is an accepted
practice for ESRD patients.7,8Table 5 Statewise teledensity in India.
Telecom circle Wireless subscribe
Delhi 42.95
Tamil Nadu 78.96
Himachal Pradesh 7.41
Punjab 31.17
Kerala and Lakshadweep 34.51
Karnataka 56.63
Maharashtra and Goa 71.00
Gujarat, Daman and Diu 54.32
Haryana 23.00
West Bengal 46.79
Andhra Pradesh 66.60
Rajastan 49.52
North East 8.76
Orissa 26.27
Uttar Pradesh (East) 77.74
Uttar Pradesh (West) and Uttarakhand 55.12
Jammu and Kashmir 6.57
Madhya Pradesh and Chhattisgarh 53.30
Bihar and Jharkhand 62.97
Assam 14.60
India 929.37The specially prepared financial questionnaire used in
this study was used to collect information about the annual
treatment cost. It included questions about nonmedical
expenses associated with dialysis, costs due to complica-
tions (with or without hospitalization), income lost due to
reduced number of effective work hours, burden on family
members, and costs associated with laboratory testing and
diagnostics other than basic treatment expenses (Figs. 1e4).
Patients from all groups had comparable demographics
and other factors. Table 2 gives a brief summary of all patient
groups’ data. Our rural PD patients were remotelymonitored
using the same system that we have described earlier.
Analysis of results from the BDI questionnaires suggests no
appreciable difference in depression levels faced by all types
of patients PD or HD, rural or urban. Results of depression
level testing are shown in the following histogram.
Comparison of quality of life of the patients using the SF-
36 scores revealed no statistically significant difference
between rural and urban PD patients. However, there is a
considerable difference between PD patients and HD pa-
tients. This difference in perceived quality of life may be
attributable to factors such as lesser time and incapacita-
tion due to treatment, more independence, and partici-
pation in vocational and community activities.r base in millions (May 2012) Teledensity (May 2012)
239.91
118.29
112.29
110.22
107.85
98.22
96.71
92.56
90.86
80.56
80.46
73.26
64.74
64.73
62.65 (combined)
62.65 (combined)
56.92
55.38
48.37
47.70
79.28
12 A. Nayak Karopadi et al.A summary of all quality of life (SF-36) results of the
study is shown in Table 3.
Our economic survey revealed that there is a statistically
significant difference in yearly treatment costs between
rural PD patients and urban PD patients. Although there
were minor differences in basic treatment costs, laboratory
testing costs, and costs due to complications, it was found
that urban PD patients spend a considerably higher amount
for erythropoietin and nonmedical hidden expenses such as
traveling to the clinic and reduction in number of work
hours due to treatment.11,19,27,28
Table 4 provides a summary of the results of our eco-
nomic survey.Conclusions
From our two studies,12,31 we can infer that with the help
of remote monitoring our rural patients performed as well
as our urban patients in most areas. In our first study,
patient survival in rural patients was significantly better
than that of urban patients. In our second study, there was
no significant difference between rural and urban patients
in terms of BDI scores and quality of life. This corroborates
our assertion that remote monitoring can ensure good
therapy regardless of the patient’s geographical location.
Finally, we see that rural patients spend significantly
less per year, owing to reduced number of visits to the
hospital, fewer hospitalized days, and lesser number of
nephrologist consultations. Although the patient groups
were clinically equivalent, we must take into consider-
ation that rural lifestyle promotes patient independence,
healthy diet, and healthy lifestyle owing to increased
physical activity. This is a major contributing factor to
better patient rehabilitation.
The purpose of this article is to highlight the importance
of remote monitoring for a successful PD program. In our
experience with remote monitoring of PD patients in India,
we would like to emphasize the role of technology in terms
of the use of digital cameras and SMS technology. Remote
monitoring in a country such as India is a viable option
owing to the vast mobile phone coverage. According to a
report by ImaginMor,29 there are nearly 930 million mobile
phones being used in India at present. Teledensity is a
statistic that gives us an estimate of how many telephone
connections are there in an area for every hundred in-
dividuals. The 2012 teledensity was 79.28 or 79.28 tele-
phone connections for every 100 people in India. Table 5
gives the statewise teledensity in various parts of the
country.29
We have also realized that technology alone is not
enough to make remote monitoring viable. A well-trained,
well-coordinated, and highly motivated PD team is
extremely important. These professionals are responsible
for conducting regular home visits, conducting training
sessions, and ensuring that patients are doing well on
therapy. We hope that our PD remote monitoring system
will give rise to other remote monitoring systems in other
countries to help improve PD therapy all over the world.
From an economic standpoint, the results of our two studies
should help people realize that it is a worthwhile invest-
ment. PD is a therapy that can potentially offer manyadvantages, but only if it is performed correctly, safely, and
religiously.
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